My Application Form Status

Check the status of your application form with Angel Broking.
Kitex Garments firms up after board approves additional investment in Kitex USA LLC
Jan 09,2017

The announcement was made during trading hours today, 9 January 2017.

Meanwhile, the BSE Sensex was up 3.81 points, or 0.01%, to 26,763.04.

On the BSE, so far 26,000 shares were traded in the counter, compared with average daily volumes of 14,686 shares in the past one quarter. The stock had hit a high of Rs 439.90 and a low of Rs 414 so far during the day.

The stock hit a 52-week high of Rs 687 on 8 January 2016. The stock hit a 52-week low of Rs 340 on 29 February 2016.

The small-cap company has equity capital of Rs 4.75 crore. Face value per share is Re 1.

Kitex Garments said its board approved further investment upto $1 million in the capital of Kitex USA LLC during the fourth quarter of 2016-2017. The board also approved availing an additional term loan of Rs 17 crore under A-TUFS with a tenure of 5 years.

Kitex Garments net profit fell 52.41% to Rs 12.92 crore on 20.5% decline in net sales to Rs 95.55 crore in Q2 September 2016 over Q2 September 2015.

Kitex Garments is a producer of childrens apparel.

Powered by Capital Market - Live News

Tata Motors gains as JLR sales rise in December
Jan 09,2017

The announcement was made during market hours today, 9 January 2017.

Meanwhile, the S&P BSE Sensex was up 13.12 points or 0.05% at 26,772.35

On the BSE, 3.04 lakh shares were traded on the counter so far as against the average daily volumes of 5.40 lakh shares in the past one quarter. The stock had hit a high of Rs 504.45 and a low of Rs 492.55 so far during the day.

The stock had hit a 52-week high of Rs 598.60 on 7 September 2016 and a 52-week low of Rs 266 on 11 February 2016.

The large-cap company has equity capital of Rs 577.44 crore. Face value per share is Rs 2.

Tata Motors said that the sales growth was primarily driven by the ongoing success of the Jaguar F-PACE, Land Rover Discovery Sport and the Range Rover Sport as well as strong demand for the long wheel base Jaguar XFL in China. Jaguars retail sales jumped 95% to 16,349 units in December 2016 over December 2015. Land Rover retail sales fell 5% to 39,026 units in December 2016 over December 2015.

On 4 January 2017, Jaguar Land Rover (JLR) announced its US retail sales for the month of December 2016. JLRs US sales rose 30% to 12,573 units in December 2016 over December 2015. Jaguar sales jumped 259% to 4,294 units in December 2016 over December 2015. Land Rover sales declined 2% to 8,279 units in December 2016 over December 2015.

Tata Motors reported consolidated net profit of Rs 848.16 crore in Q2 September 2016, compared with net loss of Rs 1740.20 crore in Q2 September 2015. Net sales rose 6.7% to Rs 65140.75 crore in Q2 September 2016 over Q2 September 2015.

Tata Motors is a market leader in commercial vehicles in India. The companys British luxury unit Jaguar Land Rover (JLR) sells premium luxury cars.

Powered by Capital Market - Live News

Tata Steel moves higher after announcing strong Q3 sales
Jan 09,2017

The announcement was made during market hours today, 9 January 2017.

Meanwhile, the S&P BSE Sensex was up 9.54 points, or 0.04%, to 26,768.77

On the BSE, 14.07 lakh shares were traded on the counter so far as against the average daily volumes of 7.69 lakh shares in the past one quarter. The stock had hit a high of Rs 423.90 and a low of Rs 419.40 so far during the day. The stock hit a 52-week high of Rs 440.90 on 11 November 2016. The stock hit a 52-week low of Rs 211.30 on 12 February 2016.

The large-cap company has equity capital of Rs 971.22 crore. Face value per share is Rs 10.

Tata Steel said that the growth in sales was enabled by higher sales in the automotive segment, branded products and value-added products & scaling up of sales in new segments.

Separetely, the company announced that it has inaugurated the second phase of cold rolling mill (CRM) complex BARA at Jamshedpur on 5 January 2017. During phase I, the reversing mill of 0.25 million tonnes per annum (MTPA) capacity was installed at CRM BARA to meet the full hard cold rolled (FHCR) requirement of Tata Blue Scope (TBSL). The phase II expansion of CRM BARA includes installation of 0.3 MTPA hot rolled skin passing mill (HSPM) to meet the increased demand of hot-rolled, pickled, skin passed and oiled products (HRSPO) in the automotive sector for high-end customers. The announcement was made on Saturday, 7 January 2017.

On a consolidated basis, Tata Steel reported net loss of Rs 49.38 crore in Q2 September 2016, compared with net profit of Rs 5609.43 crore in Q2 September 2015. Net sales rose 0.1% to Rs 26291.86 crore in Q2 September 2016 over Q2 September 2015.

Tata Steel Group stands among the top global steel companies with an annual crude steel capacity of 28 million tonnes per annum (MnTPA) and a turnover of $17.69 billion in the year ended 31 March 2016. It is the worlds second-most geographically-diversified steel producer, with operations in 26 countries and commercial presence in over 50 countries.

Powered by Capital Market - Live News

Volumes jump at Pokarna counter
Jan 09,2017

Pokarna clocked volume of 65,000 shares by 13:52 IST on BSE, a 121.99-times surge over two-week average daily volume of 1,000 shares. The stock rose 17.40% to Rs 1,080 after the company said its subsidiary entered into partnership agreement with IKEA India. The announcement was made after market hours on Friday, 06 January 2017.

Graphite India notched up volume of 7.38 lakh shares, a 49.70-fold surge over two-week average daily volume of 15,000 shares. The stock rose 16.26% to Rs 91.50.

Balmer Lawrie Investments saw volume of 3.01 lakh shares, a 40.96-fold surge over two-week average daily volume of 7,000 shares. The stock rose 7.45% to Rs 400.05.

Indian Hotels Company clocked volume of 10.37 lakh shares, a 20.03-fold surge over two-week average daily volume of 52,000 shares. The stock rose 1.77% to Rs 97.60.

BEML saw volume of 6.87 lakh shares, a 19.72-fold rise over two-week average daily volume of 35,000 shares. The stock rose 13.86% to Rs 1,131 after the government approved a 26% stake sale in the state-run company to the strategic buyers. The announcement was made after market hours on Friday, 6 January 2017.

Powered by Capital Market - Live News

Granules India tumbles after getting 11 observations from Portuguese drug regulator
Jan 09,2017

The announcement was made after market hours on Friday, 6 January 2017.

Meanwhile, the S&P BSE Sensex was up 3 points or 0.01% at 26,762.23

On the BSE, 10.81 lakh shares were traded on the counter so far as against the average daily volumes of 1.51 lakh shares in the past one quarter. The stock had hit a high of Rs 107.10 and a low of Rs 97.80 so far during the day. The stock had hit a 52-week high of Rs 151.15 on 14 August 2016. The stock had hit a 52-week low of Rs 91.45 on 9 November 2016.

The small-cap company has equity capital of Rs 22.12 crore. Face value per share is Re 1.

Granules India announced that Infarmed, Portugal, had conducted a renewal inspection on the companys facility located at Gagillapur, Telangana. In this respect, the company has received the inspection report from Infarmed with eleven observations. The Gagillapur facility manufactures Pharmaceuticals Formulation Intermediates (PFIs) and Finished Dosages (FDs).

The company has initiated necessary steps to address the observations of the inspection agency and will submit its response with a corrective and preventive action plan within the stipulated time, Granules India said. The company will also be requesting the Infarmed for re-inspection of the Gagillapur facility at the earliest. The company is committed to comply with all the required regulatory requirements and follow the best practices of the industry. The company acknowledges the observations as areas of continuous improvements, it added.

Granules Indias consolidated net profit rose 26.5% to Rs 40.82 crore on 3.08% growth in net sales to Rs 363.57 crore in Q2 September 2016 over Q2 September 2015.

Granules India produces finished dosages, pharmaceutical formulation intermediates and active pharmaceutical ingredients for customers in the regulated and semi-regulated markets.

Powered by Capital Market - Live News

BEML leads gainers in A group
Jan 09,2017

BEML jumped 13.75% to Rs 1,129.95 at 13:26 IST. The stock topped the gainers in the BSEs A group. On the BSE, 6.75 lakh shares were traded on the counter so far as against the average daily volumes of 35,000 shares in the past two weeks.

MMTC surged 13.25% to Rs 70.50. The stock was the second biggest gainer in A group. On the BSE, 35.95 lakh shares were traded on the counter so far as against the average daily volumes of 15.40 lakh shares in the past two weeks.

Prestige Estates Projects gained 6.03% at Rs 182.85. The stock was the third biggest gainer in A group. On the BSE, 9,052 shares were traded on the counter so far as against the average daily volumes of 4,364 shares in the past two weeks.

Biocon surged 4.82% at Rs 1,004.15. The stock was the fourth biggest gainer in A group. On the BSE, 1.61 lakh shares were traded on the counter so far as against the average daily volumes of 41,000 shares in the past two weeks.

Hindustan Copper rose 4.76% to Rs 64.95. The stock was the fifth biggest gainer in A group. On the BSE, 7.39 lakh shares were traded on the counter so far as against the average daily volumes of 4.20 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Pokarna jumps after partnering IKEA India
Jan 09,2017

The announcement was made after market hours on Friday, 06 January 2017.

Meanwhile, the S&P BSE Sensex was down 11.98 points or 0.04% at 26,771.21.

On the BSE, 56,000 shares were traded on the counter so far as against the average daily volumes of 2,734 shares in the past one quarter. The stock had hit a high of Rs 1103.85 and a low of Rs 970 so far during the day.

The stock had hit a 52-week high of Rs 1,064 on 20 May 2016 and a 52-week low of Rs 660 on 17 February 2016.

The small-cap company has equity capital of Rs 6.20 crore. Face value per share is Rs 10.

Pokarnas announced that its wholly-owned subsidiary, Pokarna Engineered Stone (PESL), partnered IKEA India, to serve as its exclusive quartz surfaces supply and installation partner. Under the agreement, Pokarna will supply engineered quartz surfaces countertop and will also undertake measuring, planning, installation and home delivery of its products to IKEAs customer.

IKEA is the worlds largest home furnishing company with about 389 stores in 46 countries and a sales volume of 34.20 billion Euros.

Pokarnas consolidated net profit rose 44.60% to Rs 18.87 crore on 2.14% fall in net sales to Rs 96.49 crore in Q2 September 2016 over Q2 September 2015.

Pokarna, headquartered in Secunderabad, processes granite at its two manufacturing facilities with raw material majorly sourced from its own quarries. The companys Quartz operations are handled by its wholly-owned subsidiary Pokarna Engineered Stone.

Powered by Capital Market - Live News

Vijaya Bank rises after announcing reduction in MCLRs
Jan 09,2017

The announcement was made on Saturday, 7 January 2017.

Meanwhile, the BSE Sensex was down 22.55 points, or 0.08%, to 26,736.68

On the BSE, 17,000 shares were traded on the counter so far as against the average daily volumes of 1.44 lakh shares in the past one quarter. The stock had hit a high of Rs 49.70 and a low of Rs 49.05 so far during the day. The stock hit a 52-week high of Rs 54.45 on 11 November 2016. The stock hit a 52-week low of Rs 28.70 on 18 January 2016.

The mid-cap state-run bank has an equity capital of Rs 998.85 crore. Face value per share is Rs 10.

Vijaya Bank said that it has reduced marginal cost of funds based lending rate (MCLR) for overnight loans to 9.2% from 8.45%. The rate for one month is reduced to 9.2% from 8.5% and for three months it is reduced to 9.25% from 8.55%.

The MCLR on 6-month loans will be 9.25% from earlier 8.6% and for one-year loans the rate will be 9.45% from 8.65%, the bank said. MCLR on two-year loans was reduced to 9.5% from 8.65% and for three-year loans the rate will be 9.55% from 8.75% earlier.

Net profit of Vijaya Bank rose 34.05% to Rs 154.55 crore on 9.79% rise in total income to Rs 3516.57 crore in Q2 September 2016 over Q2 September 2015.

As per the shareholding pattern, the Government of India held 70.33% stake in the bank as at 30 September 2016.

Powered by Capital Market - Live News

MIRC Electronics jumps after allotting equity shares on preferential basis
Jan 09,2017

The announcement was made after market hours on Friday, 06 January 2017.

Meanwhile, the S&P BSE Sensex was down 9.22 points or 0.03% at 26,756.87.

On the BSE, 1.45 lakh shares were traded on the counter so far as against the average daily volumes of 1.75 lakh shares in the past one quarter. The stock had hit a high of Rs 14.70 and a low of Rs 14.06 so far during the day.

The stock had hit a 52-week high of Rs 19.40 on 7 January 2016 and a 52-week low of Rs 8.06 on 26 February 2016.

The small-cap company has equity capital of Rs 19.62 crore. Face value per share is Rs 1.

MIRC Electronics said that preferential issue committee of the company has allotted 1.55 crore equity shares Rs 14.66 per share (including a premium of Rs 13.66 per share) to Bennett Coleman & Co, being person other than promoter and /or promoter group on preferential basis.

Consequently, the paid up equity share capital of the company now stands increased from Rs 19.62 crore to 21.17 crore.

MIRC Electronics reported net loss of Rs 9.09 crore in Q2 September 2016, as compared to net loss of Rs 16.61 crore in Q2 September 2015. Net sales rise 1.5% to Rs 147.05 crore in Q2 September 2016 over Q2 September 2015.

MIRC Electronics makes electronic products such as television sets, washing machines, air conditioners, DVDs and Microwave Ovens under the Onida brand. The company also makes mobiles phones under the Onida brand.

Powered by Capital Market - Live News

Apcotex Industries drops after intimating of workmen strike at Taloja plant
Jan 09,2017

The announcement was made after market hours on Friday, 6 January 2017.

Meanwhile, the S&P BSE Sensex was down 20.83 points, or 0.08%, to 26,738.40

On the BSE, 337 shares were traded on the counter so far as against the average daily volumes of 21,416 shares in the past one quarter. The stock had hit a high of Rs 315 and a low of Rs 308.20 so far during the day.

The stock hit a record high of Rs 435 on 28 July 2016. The stock hit a 52-week low of Rs 181.50 on 12 February 2016.

The small-cap company has equity capital of Rs 10.37 crore. Face value per share is Rs 5.

Apcotex Industries said that the management is making all efforts to settle the issue amicably. The management has also made all the necessary arrangements to try and ensure that the production activities are not hampered in any way and will try and ensure to maintain normal level of operations during this period, the company said.

Apcotex Industries net profit dropped 33.21% to Rs 3.56 crore on 39.19% growth in total income to Rs 95.30 crore in Q2 September 2016 over Q2 September 2015.

Apcotex Industries is one of the leading producers of performance emulsion polymers in India. its product range includes VP latex, carboxylated and non-carboxylated SB latexes, acrylic latexes, nitrile latex and synthetic rubber.

Powered by Capital Market - Live News

Aurobindo Pharma gains after getting USFDA approval for Levetiracetam
Jan 09,2017

The announcement was made on Saturday, 7 January 2017.

Meanwhile, the S&P BSE Sensex was up 6.28 points, or 0.02%, to 26,765.51

On the BSE, so far 1.35 lakh shares were traded in the counter, compared with average daily volumes of 1.81 lakh shares in the past one quarter. The stock had hit a high of Rs 725 and a low of Rs 706.10 so far during the day. The stock hit a record high of Rs 895 on 6 October 2016. The stock hit a 52-week low of Rs 582 on 25 February 2016.

The large-cap company has equity capital of Rs 58.52 crore. Face value per share is Re 1.

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levetiracetam in Sodium Chloride Injection, 500 mg/100 mL (5 mg/mL), 1000 mg/100 mL (10 mg/mL), and 1500 mg/100 mL (15 mg/mL) (single-use bags). Aurobindos Levetiracetam in Sodium Chloride Injection is a generic equivalent of HQ Specialty Pharma Corps Levetiracetam in Sodium Chloride Injection. The product will be launched in January 2017.

Levetiracetam in Sodium Chloride Injection is a CNS drug and indicated for partial onset seizures in adults (16 years and older) with epilepsy; myoclonic seizures in adults with juvenile myoclonic epilepsy; primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. The approved product has an estimated market size of $32 million for the twelve months ended November 2016, according to IMS.

This is the 41st Abbreviated New Drug Application (ANDA) (including 2 tentative approvals) to be approved out of unit IV formulation facility in Hyderabad used for manufacturing general injectable products. Aurobindo now has a total of 304 ANDA approvals (263 final approvals including 16 from Aurolife Pharma LLC and 41 tentative approvals) from USFDA.

Separately, Aurobindo Pharmas wholly owned step-down subsidiary Agile Pharma B.V., Netherlands has announcing signing of a binding agreement to acquire Generis Farmaceutica S.A for 135 million euro from Magnum Capital Partners. Generis is engaged in manufacture and sale of pharmaceutical products in Portugal. The acquisition includes the manufacturing facility in Amadora, Portugal, which has the capacity to produce 1.2 billion tablets/capsules/sachets annually.

This deal consolidates Aurobindos footprint in Portugal, which currently consists of Aurovitas, Unipessoal LDA and Aurobindo Pharma (Portugal), Unipessoal Limitada, the company said. The management estimates that the net sales for the acquired business will be approximately 72 million euros in 2017, compared to 64.8 million euros in 2016. Adjusted Earnings before interest, tax, depreciation and amortization (EBITDA) estimate for 2016 is 12.7 million euros, which is projected to improve to 15.8 million euros in 2017, Aurobindo Pharma said.

On consolidated basis, Aurobindo Pharmas net profit rose 33.53% to Rs 605.64 crore on 12.03% growth in total income to Rs 3783.73 crore in Q2 September 2016 over Q2 September 2015.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The companys product portfolio is spread over 7 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, Anti-Allergies and Anti-Diabetics, supported by an outstanding R&D set-up. The company is marketing these products globally, in over 150 countries.

Powered by Capital Market - Live News

BEML surges as government to offload 26% stake
Jan 09,2017

The announcement was made after market hours on Friday, 6 January 2017.

Meanwhile, the BSE Sensex was down 2.68 points, or 0.01%, to 26,756.56

On BSE, so far 2.08 lakh shares were traded in the counter, compared with an average volume of 31,971 shares in the past one quarter. The stock hit a high of Rs 1,147.05 and a low of Rs 977.10 so far during the day. The stock hit a 52-week high of Rs 1,247.05 on 11 January 2016. The stock hit a 52-week low of Rs 770.15 on 23 November 2016.

The mid-cap company has an equity capital of Rs 41.64 crore. Face value per share is Rs 10.

BEML said that the Government of India, Ministry of Defence, has communicated in-principal approval of the Cabinet Committee on Economic Affairs (CCEA) of the Government of India, for strategic disinvestment of 26% equity shares in the company out of Government of India shareholding of 54.03%. The shareholding would be sold to the strategic buyer/s to be identified by the Government of India by following due procedure.

BEML reported net loss of Rs 16.60 crore in Q2 September 2016, lower than net loss of Rs 24.62 crore in Q2 September 2015. Net sales dropped 32.98% to Rs 450.79 crore in Q2 September 2016 over Q2 September 2015.

BEML was established in May 1964 as a public sector undertaking for manufacture of rail coaches & spare parts and mining equipment at its Bangalore complex. The Government of India held 54.03% stake BEML (as per the shareholding pattern as on 30 September 2015).

Powered by Capital Market - Live News

Apar tumbles as board approves buyback at nominal premium
Jan 06,2017

The announcement was made during market hours today, 6 January 2017.

Meanwhile, the S&P BSE Sensex was down 113.45 points or 0.42% at 26,764.79.

On the BSE, 25,000 shares were traded on the counter so far as against the average daily volumes of 15,445 shares in the past one quarter. The stock had hit a high of Rs 659.85 and a low of Rs 607.50 so far during the day.

The stock had hit a record high of Rs 666 yesterday, 5 January 2017 and a 52-week low of Rs 406 on 29 February 2016.

The small-cap company has equity capital of Rs 38.50 crore. Face value per share is Rs 10.

Apar Industries board at its meeting held today, 6 January 2017, approved the buyback up to 4.50 lakh fully paid-up equity shares, representing up to 1.17% of the outstanding equity shares of the company at a price of Rs 660 per share payable in cash for an aggregate amount of up to Rs 29.70 crore.

The buyback represents 4.09% of the fully paid-up equity share capital and free reserves (including securities premium) as per the standalone audited balance sheet of the company for the year ended 31 March 2016. The buyback will be on a proportionate basis through the tender offer. The promoters of the company have indicated their intention to participate in the proposed buyback. Promoters held 58.21% stake in Apar Industries end September 2016.

The record date for the proposed buyback is 20 January 2017.

Apar Industries net profit rose 82.2% to Rs 45.66 crore on 1.5% rise in net sales to Rs 1252.58 crore in Q2 September 2016 over Q2 September 2015.

Apar Industries is engaged in the business of manufacture of conductors, transformer/specialty oils and power/telecom cables.

Powered by Capital Market - Live News

Religare Enterprises gains after subsidiary signs pact to divest stake in its unit
Jan 06,2017

The announcement was made during market hours today, 6 January 2017.

Meanwhile, the BSE Sensex was down 95.87 points, or 0.36%, to 26,782.37.

On the BSE, so far 6,029 shares were traded in the counter, compared with average daily volumes of 3,767 shares in the past one quarter. The stock had hit a high of Rs 264 and a low of Rs 250 so far during the day. The stock had hit a 52-week high of Rs 319 on 3 February 2016. The stock had hit a 52-week low of Rs 221.05 on 15 November 2016.

The stock had underperformed the market over the past one month till 5 January 2017, falling 6.94% compared with the Sensexs 2.01% rise. The scrip had also underperformed the market in past one quarter, dropping 8.05% as against the Sensexs 4.76% fall.

The mid-cap company has equity capital of Rs 178.33 crore. Face value per share is Rs 10.

Religare Enterprises announced that RGAM Investment Advisers Private Limited, a wholly-owned subsidiary of the company, has entered into definitive agreements on 5 January 2017 for the divestment of its stake in its wholly-owned subsidiary, Cerestra Advisors Limited, with TCP-Cerestra Ltd, a company registered under the laws of Cayman Islands; Cerestra Managers Pvt Ltd, a company registered under the laws of India; and Elephant India Finance limited, a company registered under the laws of India.

The stake will be bought by The Capital Partnership Group. The transaction is expected to be closed by28 February 2017 following the receipt of all required regulatory approvals.

Religare Enterprises had announced on 29 July 2016 that RGAM Investment Advisers has executed a binding term sheet to divest its stake in Cerestra Advisors Limited (Cerestra).

Religare Enterprises reported net loss of Rs 39.54 crore in Q2 September 2016 as against net loss of Rs 13.90 crore in Q2 September 2015. Total income declined 38.4% to Rs 11.85 crore in Q2 September 2016 over Q2 September 2015.

Religare Enterprises (REL) is the holding company for one of Indias leading diversified financial services groups. REL offers an integrated suite of financial services through its underlying subsidiaries and operating entities, including loans to SMEs, affordable housing finance, health insurance, capital markets and wealth management.

Powered by Capital Market - Live News

Idea Cellular declines on brokerage downgrade
Jan 06,2017

Meanwhile, the S&P BSE Sensex was down 92.62 points or 0.34% at 26,785.62.

On the BSE, 3.35 lakh shares were traded on the counter so far as against the average daily volumes of 6.97 lakh shares in the past one quarter. The stock had hit a high of Rs 74.65 and a low of Rs 72.70 so far during the day.

The stock had hit a 52-week high of Rs 137.85 on 6 January 2016 and a 52-week low of Rs 66 on 9 November 2016. It had outperformed the market over the past one month till 5 January 2017, advancing 2.75% compared with the Sensexs 2.01% rise. The scrip had, however, underperformed the market in past one quarter, declining 6.57% as against the Sensexs 4.76% fall.

The large-cap company has equity capital of Rs 3601.69 crore. Face value per share is Rs 10.

The brokerage sees significant decline in operating profit of Idea Cellular going forward. Unlimited voice uptake makes risk-reward unfavourable, it added.

On a consolidated basis, Idea Cellulars net profit fell 88% to Rs 91.46 crore on 7.2% growth in net sales to Rs 9298.89 crore in Q2 September 2016 over Q2 September 2015.

Idea Cellular is the third largest wireless operator in India. Idea is part of the Aditya Birla Group, which is one of the largest business groups in India.

Powered by Capital Market - Live News